Han et al. showed that miR-181c directly targets OPN and that its overexpression significantly inhibited breast cancer cell proliferation, reversed doxorubicin chemoresistance, and reduced breast cancer xenograft growth [34]. The gene discussed is SPP1; the disease is breast cancer.